TD Asset Management Inc Decreases Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• TD Asset Management Inc reduced its holdings in Oscar Health, Inc. (NYSE:OSCR) by 6.8% in Q1, owning 673,232 shares valued at approximately $8.83 million after a sale of 49,208 shares.
• Oscar Health's quarterly earnings surpassed expectations with earnings per share of $0.92, exceeding the consensus estimate of $0.83, while net revenue increased 42.2% year-over-year to $3 billion.
• Analysts have a consensus rating of "Hold" on Oscar Health stock, with target prices ranging as low as $11.00 following recent downgrades from several firms.

TD Asset Management Inc trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 6.8% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 673,232 shares of the company's stock after selling 49,208 shares during the quarter. TD Asset Management Inc owned about 0.27% of Oscar Health worth $8,826,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of OSCR. Larson Financial Group LLC grew its stake in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after purchasing an additional 2,512 shares during the period. CWM LLC grew its stake in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after purchasing an additional 1,078 shares during the period. Princeton Global Asset Management LLC bought a new stake in shares of Oscar Health during the 1st quarter valued at about $59,000. GAMMA Investing LLC grew its stake in shares of Oscar Health by 2,156.4% during the 1st quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock valued at $85,000 after purchasing an additional 6,189 shares during the period. Finally, Tower Research Capital LLC TRC grew its stake in shares of Oscar Health by 171.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after purchasing an additional 4,185 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on OSCR shares. Barclays cut their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, July 23rd. UBS Group reiterated a "sell" rating and set a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Finally, Piper Sandler downgraded Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a research note on Monday, July 14th. Five equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $12.21.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director directly owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 25.11% of the company's stock.

Oscar Health Price Performance

NYSE OSCR traded down $0.06 during trading hours on Tuesday, reaching $13.78. The company's stock had a trading volume of 11,274,242 shares, compared to its average volume of 12,940,403. The firm's 50-day moving average price is $15.86 and its 200-day moving average price is $14.88. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 49.11 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same period in the previous year, the firm earned $0.62 EPS. The firm's revenue was up 42.2% compared to the same quarter last year. On average, equities research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.